vs
Side-by-side financial comparison of Colgate-Palmolive (CL) and CRH PUBLIC LTD CO (CRH). Click either name above to swap in a different company.
CRH PUBLIC LTD CO is the larger business by last-quarter revenue ($9.4B vs $5.2B, roughly 1.8× Colgate-Palmolive). CRH PUBLIC LTD CO runs the higher net margin — 10.9% vs -0.7%, a 11.6% gap on every dollar of revenue. On growth, CRH PUBLIC LTD CO posted the faster year-over-year revenue change (6.2% vs 5.8%). Over the past eight quarters, CRH PUBLIC LTD CO's revenue compounded faster (20.1% CAGR vs 1.6%).
The Colgate-Palmolive Company, commonly known as Colgate-Palmolive, is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. The company specializes in the production, distribution, and provision of household, health care, personal care, and veterinary products.
CRH plc is a building materials provider headquartered in Dublin. CRH produces construction materials, primarily aggregates and cement, and manufactures ready-mixed concrete, asphalt concrete, and infrastructural components, of which it is one of the largest suppliers in North America. CRH operates with 3,816 locations in 28 countries in North America, Europe, Australia, and the Philippines.
CL vs CRH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.2B | $9.4B |
| Net Profit | $-36.0M | $1.0B |
| Gross Margin | 60.2% | 35.6% |
| Operating Margin | 1.7% | 14.9% |
| Net Margin | -0.7% | 10.9% |
| Revenue YoY | 5.8% | 6.2% |
| Net Profit YoY | -104.9% | 45.8% |
| EPS (diluted) | $-0.04 | $1.51 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.2B | $9.4B | ||
| Q3 25 | $5.1B | $11.1B | ||
| Q2 25 | $5.1B | $10.2B | ||
| Q1 25 | $4.9B | $6.8B | ||
| Q4 24 | $4.9B | $8.9B | ||
| Q3 24 | $5.0B | $10.5B | ||
| Q2 24 | $5.1B | $9.7B | ||
| Q1 24 | $5.1B | $6.5B |
| Q4 25 | $-36.0M | $1.0B | ||
| Q3 25 | $735.0M | $1.5B | ||
| Q2 25 | $743.0M | $1.3B | ||
| Q1 25 | $690.0M | $-94.0M | ||
| Q4 24 | $738.0M | $703.0M | ||
| Q3 24 | $737.0M | $1.4B | ||
| Q2 24 | $731.0M | $1.3B | ||
| Q1 24 | $683.0M | $116.0M |
| Q4 25 | 60.2% | 35.6% | ||
| Q3 25 | 59.4% | 38.9% | ||
| Q2 25 | 60.1% | 39.4% | ||
| Q1 25 | 60.8% | 27.2% | ||
| Q4 24 | 60.3% | 35.6% | ||
| Q3 24 | 61.1% | 38.6% | ||
| Q2 24 | 60.6% | 38.1% | ||
| Q1 24 | 60.0% | 27.7% |
| Q4 25 | 1.7% | 14.9% | ||
| Q3 25 | 20.6% | 18.8% | ||
| Q2 25 | 21.1% | 19.0% | ||
| Q1 25 | 21.9% | 0.3% | ||
| Q4 24 | 21.5% | 12.4% | ||
| Q3 24 | 21.2% | 18.7% | ||
| Q2 24 | 21.6% | 18.9% | ||
| Q1 24 | 20.7% | 0.4% |
| Q4 25 | -0.7% | 10.9% | ||
| Q3 25 | 14.3% | 13.6% | ||
| Q2 25 | 14.5% | 12.9% | ||
| Q1 25 | 14.1% | -1.4% | ||
| Q4 24 | 14.9% | 7.9% | ||
| Q3 24 | 14.6% | 13.1% | ||
| Q2 24 | 14.5% | 13.4% | ||
| Q1 24 | 13.5% | 1.8% |
| Q4 25 | $-0.04 | $1.51 | ||
| Q3 25 | $0.91 | $2.21 | ||
| Q2 25 | $0.91 | $1.94 | ||
| Q1 25 | $0.85 | $-0.15 | ||
| Q4 24 | $0.89 | $1.01 | ||
| Q3 24 | $0.90 | $1.97 | ||
| Q2 24 | $0.89 | $1.88 | ||
| Q1 24 | $0.83 | $0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $4.1B |
| Total DebtLower is stronger | $7.8B | $17.5B |
| Stockholders' EquityBook value | $54.0M | $24.0B |
| Total Assets | $16.3B | $58.3B |
| Debt / EquityLower = less leverage | 145.17× | 0.73× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $4.1B | ||
| Q3 25 | $1.3B | $4.2B | ||
| Q2 25 | $1.2B | $2.9B | ||
| Q1 25 | $1.1B | $3.4B | ||
| Q4 24 | $1.3B | $3.7B | ||
| Q3 24 | $1.2B | $3.0B | ||
| Q2 24 | $1.1B | $3.1B | ||
| Q1 24 | $1.1B | $3.3B |
| Q4 25 | $7.8B | $17.5B | ||
| Q3 25 | — | $18.6B | ||
| Q2 25 | — | $15.7B | ||
| Q1 25 | — | $15.6B | ||
| Q4 24 | $7.0B | $13.9B | ||
| Q3 24 | — | $13.7B | ||
| Q2 24 | — | $13.0B | ||
| Q1 24 | — | $12.6B |
| Q4 25 | $54.0M | $24.0B | ||
| Q3 25 | $856.0M | $23.3B | ||
| Q2 25 | $702.0M | $22.3B | ||
| Q1 25 | $363.0M | $21.1B | ||
| Q4 24 | $212.0M | $21.6B | ||
| Q3 24 | $435.0M | $21.9B | ||
| Q2 24 | $123.0M | $20.7B | ||
| Q1 24 | $230.0M | $20.0B |
| Q4 25 | $16.3B | $58.3B | ||
| Q3 25 | $17.5B | $58.5B | ||
| Q2 25 | $17.5B | $54.0B | ||
| Q1 25 | $16.6B | $51.9B | ||
| Q4 24 | $16.0B | $50.6B | ||
| Q3 24 | $16.8B | $51.2B | ||
| Q2 24 | $16.5B | $48.1B | ||
| Q1 24 | $16.6B | $46.3B |
| Q4 25 | 145.17× | 0.73× | ||
| Q3 25 | — | 0.80× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.74× | ||
| Q4 24 | 33.04× | 0.64× | ||
| Q3 24 | — | 0.63× | ||
| Q2 24 | — | 0.63× | ||
| Q1 24 | — | 0.63× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.5B | $2.9B |
| Free Cash FlowOCF − Capex | $1.3B | — |
| FCF MarginFCF / Revenue | 24.4% | — |
| Capex IntensityCapex / Revenue | 3.4% | — |
| Cash ConversionOCF / Net Profit | — | 2.84× |
| TTM Free Cash FlowTrailing 4 quarters | $3.6B | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5B | $2.9B | ||
| Q3 25 | $1.3B | $2.0B | ||
| Q2 25 | $884.0M | $1.4B | ||
| Q1 25 | $600.0M | $-659.0M | ||
| Q4 24 | $1.3B | $2.7B | ||
| Q3 24 | $1.2B | $1.5B | ||
| Q2 24 | $990.0M | $1.5B | ||
| Q1 24 | $681.0M | $-712.0M |
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $776.0M | $723.0M | ||
| Q1 25 | $476.0M | $-1.3B | ||
| Q4 24 | $1.1B | $1.8B | ||
| Q3 24 | $1.0B | $981.0M | ||
| Q2 24 | $873.0M | $861.0M | ||
| Q1 24 | $555.0M | $-1.2B |
| Q4 25 | 24.4% | — | ||
| Q3 25 | 21.6% | — | ||
| Q2 25 | 15.2% | 7.1% | ||
| Q1 25 | 9.7% | -19.3% | ||
| Q4 24 | 21.9% | 20.1% | ||
| Q3 24 | 20.5% | 9.3% | ||
| Q2 24 | 17.3% | 8.9% | ||
| Q1 24 | 11.0% | -18.6% |
| Q4 25 | 3.4% | — | ||
| Q3 25 | 3.0% | — | ||
| Q2 25 | 2.1% | 6.4% | ||
| Q1 25 | 2.5% | 9.5% | ||
| Q4 24 | 3.7% | 10.6% | ||
| Q3 24 | 2.7% | 4.8% | ||
| Q2 24 | 2.3% | 6.5% | ||
| Q1 24 | 2.5% | 7.7% |
| Q4 25 | — | 2.84× | ||
| Q3 25 | 1.72× | 1.32× | ||
| Q2 25 | 1.19× | 1.04× | ||
| Q1 25 | 0.87× | — | ||
| Q4 24 | 1.72× | 3.88× | ||
| Q3 24 | 1.58× | 1.08× | ||
| Q2 24 | 1.35× | 1.14× | ||
| Q1 24 | 1.00× | -6.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CL
| Other | $3.0B | 58% |
| Pet Nutrition | $1.2B | 23% |
| Oral Personal And Home Care | $1.0B | 20% |
CRH
| Products | $7.1B | 76% |
| Essential Materials | $1.4B | 15% |
| Outdoor Living Solutions | $842.0M | 9% |
